In response to the FDA advisory panel’s findings that phenylephrine, the active ingredient, is ineffective for relieving nasal congestion, CVS has taken the initiative to remove select oral cough and cold medications from their stores. A CVS representative stated, “We are proactively removing specific oral cough and cold products containing phenylephrine as the sole active ingredient from CVS Pharmacy outlets.”
The FDA’s Nonprescription Drugs Advisory Committee (NDAC) has concluded that orally using phenylephrine to address nasal congestion does not yield the desired results. Although the FDA has yet to make a definitive judgment on this product, CVS has decided to withdraw it from its inventory. Other retail chains like Walgreens and Rite Aid are closely monitoring the situation. The FDA has emphasized that the panel’s recommendations pertain exclusively to orally administered phenylephrine, not the nasal spray variety. Some medications utilize phenylephrine as the sole active component, while others combine it with additional active ingredients like acetaminophen or ibuprofen to treat various symptoms.
The FDA encourages consumers to carefully review drug facts labels to understand a medication’s components and follow crucial usage instructions. In the event that the FDA concludes that oral phenylephrine is ineffective, the agency has expressed its intention to collaborate with manufacturers to reformulate products, ensuring the availability of safe and efficient treatments for cold and allergy symptoms.